Mulvaney Sean W
Uniformed Services University, Kimbrough Ambulatory Care Center, Fort Meade, MD, USA.
Curr Sports Med Rep. 2009 Nov-Dec;8(6):291-4. doi: 10.1249/JSR.0b013e3181c2212f.
Viscosupplementation of the hip for symptomatic osteoarthritis appears to be safe and effective in more than 25 yr of use in Europe. More than 11 studies suggest that viscosupplementation in the hip is as effective as viscosupplementation in the knee. It appears to be a safe and reasonable alternative to nonsteroidal antiinflammatory drugs or intra-articular steroids for the treatment of osteoarthritis pain. Viscosupplementation in the hip may delay the need for hip replacement surgery. Viscosupplementation in the hip appears to work better in patients with fewer radiographic changes of osteoarthritis. Placement of viscosupplement in the hip under real-time ultrasound or fluoroscopic guidance is safe and well tolerated. Hip joint communication with the iliopsoas bursa may be a factor in studies of the effectiveness of viscosupplementation in the hip.
在欧洲，用于治疗症状性骨关节炎的髋关节粘弹性补充疗法在超过25年的应用中似乎是安全有效的。超过11项研究表明，髋关节粘弹性补充疗法与膝关节粘弹性补充疗法效果相当。对于骨关节炎疼痛的治疗，它似乎是一种安全且合理的替代非甾体抗炎药或关节内注射类固醇的方法。髋关节粘弹性补充疗法可能会推迟髋关节置换手术的需求。在骨关节炎影像学改变较少的患者中，髋关节粘弹性补充疗法似乎效果更好。在实时超声或荧光透视引导下将粘弹性补充剂注入髋关节是安全的，且耐受性良好。髋关节与髂腰肌滑囊的连通性可能是影响髋关节粘弹性补充疗法有效性研究的一个因素。
